// App-Quantinova.ai

4009 : The expression of PD-L1 on human and murine pancreatic ductal adenocarcinoma is enhanced by anticancer agents via the JAK/STAT pathway

Researchers

Presenter

  • Toshifumi Doi

Principal Investigators

  • Takeshi Ishikawa

  • Tomoyo Yasuda

  • Tetsuya Okayama

  • Kaname Oka

  • Naoyuki Sakamoto

  • Yuji Naito

  • Yoshito Itoh

Medical Centers

  • Takeda Clinic, Kyoto, Japan

  • Hyakumanben Clinic, Kyoto, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Janus kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved